Home > Insider Trading > Filing (0000899243-19-024005)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	Pharmaceutical Preparations (2834)	455500552

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1696493	June Lee	C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080	Evp, Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-19	5,435	$11.95	10,014	No	4	M	Direct
Common Stock	Disposition	2019-09-19	5,435	$57.08	4,579	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-09-19	5,435	$0.00	5,435	$11.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
128,242		2027-01-31	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $57.00 to $57.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.